Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type Interaction Map description Network Comparison Type Rank Gene Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 512 to 561 of 3228 in total 
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
casein kinase i, gamma 1 isoform (ec 2.7.1.-) (cki-gamma 1). [source:swissprot;acc:q9hcp0]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2830\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
casein kinase i, gamma 2 isoform (ec 2.7.1.-) (cki-gamma 2). [source:swissprot;acc:p78368]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2986\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
casein kinase i, gamma 3 isoform (ec 2.7.1.-) (cki-gamma 3). [source:swissprot;acc:q9y6m4]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2901\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
casein kinase ii beta chain (ck ii) (phosvitin) (g5a). [source:swissprot;acc:p13862]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1245\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4835.55\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5243.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08431\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
casein kinase ii, alpha chain (ck ii) (ec 2.7.1.37). [source:swissprot;acc:p19138]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
851\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4307.12\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4755.03\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.10399\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
casein kinase ii, alpha' chain (ck ii) (ec 2.7.1.37). [source:swissprot;acc:p19784]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
852\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
caspase-7 precursor (ec 3.4.22.-) (ice-like apoptotic protease 3) (ice-lap3) (apoptotic protease mch-3) (cmh-1). [source:swissprot;acc:p55210]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
948\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4633.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5084.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09728\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
catenin (cadherin-associated protein), alpha-like 1; alpha-catulin. [source:refseq;acc:nm\_003798]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
616\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
11222.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9948.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12798\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cathepsin b precursor (ec 3.4.22.1) (cathepsin b1) (app secretase). [source:swissprot;acc:p07858]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
914\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6513.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7161\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09942\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cathepsin l precursor (ec 3.4.22.15) (major excreted protein) (mep). [source:swissprot;acc:p07711]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2238\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5902.27\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6181.21\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04726\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
cathepsin l2 precursor (ec 3.4.22.43) (cathepsin v) (cathepsin u). [source:swissprot;acc:o60911]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2237\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5902.26\vspace{3pt}}&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
caveolin-1. [source:swissprot;acc:q03135]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3099\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
caveolin-3 (m-caveolin). [source:swissprot;acc:p56539]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2779\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cbf1 interacting corepressor. [source:refseq;acc:nm\_004882]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1651\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5944.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6358.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06962\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cbl e3 ubiquitin protein ligase (ec 6.3.2.-) (signal transduction protein cbl) (proto-oncogene c-cbl). [source:swissprot;acc:p22681]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
507\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6875.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7858.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14302\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ccaat displacement protein (cdp) (cut-like 1). [source:swissprot;acc:p39880]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
257\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6417.31\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7858.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.22452\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ccaat-binding transcription factor subunit b (cbf-b) (nf-y protein chain a) (nf-ya) (caat-box dna binding protein subunit a). [source:swissprot;acc:p23511]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
137\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3620.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4763.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.31556\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ccaat-box-binding transcription factor (ccaat-binding factor) (cbf). [source:swissprot;acc:q03701]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
369\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3583.56\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4194.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17061\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ccr4-not transcription complex, subunit 3; not3 (negative regulator of transcription 3, yeast) homolog. [source:refseq;acc:nm\_014516]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3163\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ccr4-not transcription complex, subunit 4; not4 (negative regulator of transcription 4, yeast) homolog; ccr4-not transcription complex, subunit. [source:refseq;acc:nm\_013316]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2289\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5783.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6048.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04585\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ccr4-not transcription complex, subunit 6-like. [source:refseq;acc:nm\_144571]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2958\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
ccr4-not transcription complex, subunit 7 (ccr4-associated factor 1) (caf1) (btg1 binding factor 1). [source:swissprot;acc:q9uiv1]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3226\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
ccr4-not transcription complex, subunit 8 (caf1-like protein) (califp). [source:swissprot;acc:q9uff9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2890\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cd109; gov system alloantigens on platelets. [source:refseq;acc:nm\_133493]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1445\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5117.85\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5510.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07671\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cd209 antigen-like; putative type ii membrane protein. [source:refseq;acc:nm\_014257]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2753\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4521.42\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4521.87\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0001\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
cd209 antigen; dendritic cell-specific icam3-grabbing nonintegrin. [source:refseq;acc:nm\_021155]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2755\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cda11 protein. [source:refseq;acc:nm\_032026]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1174\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5874.11\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6387.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08735\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cdc42 guanine exchange factor 9; hpem-2 collybistin. [source:refseq;acc:nm\_015185]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1995\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6174.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6538.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05895\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cdc42-interacting protein 4 (thyroid receptor interacting protein 10) (trip-10). [source:swissprot;acc:q15642]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1611\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5497.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5132.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07119\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cdc5-like; cdc5 (cell division cycle 5, s. pombe, homolog)-like; cell division cycle 5, s. pombe, homolog-like; cdc5-related protein. [source:refseq;acc:nm\_001253]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
419\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5493.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6350.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15603\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cdk-activating kinase assembly factor mat1 (ring finger protein mat1) (menage a trois) (cdk7/cyclin h assembly factor) (p36) (p35) (cyclin g1 interacting protein). [source:swissprot;acc:p51948]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3209\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cdp-diacylglycerol--inositol 3-phosphatidyltransferase (ec 2.7.8.11) (phosphatidylinositol synthase) (ptdins synthase) (pi synthase). [source:swissprot;acc:o14735]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
981\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6654.42\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7296.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09649\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cell adhesion molecule with homology to l1cam precursor; neural cell adhesion molecule; cell adhesion molecule l1-like; l1 cell adhesion molecule 2. [source:refseq;acc:nm\_006614]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1660\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7433.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7950.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06953\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cell division control protein 2 homolog (ec 2.7.1.-) (p34 protein kinase) (cyclin-dependent kinase 1) (cdk1). [source:swissprot;acc:p06493]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
363\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12780.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10876.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17509\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cell division cycle protein 23; anaphase-promoting complex subunit 8. [source:refseq;acc:nm\_004661]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2387\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8265.85\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7940.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04092\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cell division protein kinase 2 (ec 2.7.1.-) (p33 protein kinase). [source:swissprot;acc:p24941]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
361\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12787.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10880.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17528\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cell division protein kinase 3 (ec 2.7.1.-). [source:swissprot;acc:q00526]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
359\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12798.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10887.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17559\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cell division protein kinase 5 (ec 2.7.1.-) (tau protein kinase ii catalytic subunit) (tpkii catalytic subunit) (serine/threonine protein kinase pssalre). [source:swissprot;acc:q00535]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2850\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
cell division protein kinase 8 (ec 2.7.1.-) (protein kinase k35). [source:swissprot;acc:p49336]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2990\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
cell division protein kinase 9 (ec 2.7.1.-) (serine/threonine-protein kinase pitalre) (c-2k). [source:swissprot;acc:p50750]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2974\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cellular modulator of immune recognition. [source:refseq;acc:nm\_145021]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
739\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5768.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6434.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11554\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cellular repressor of e1a-stimulated genes 2. [source:refseq;acc:nm\_153836]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
623\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6228.39\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7013.19\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.126\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
cellular repressor of e1a-stimulated genes. [source:refseq;acc:nm\_003851]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
629\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
centaurin beta 1 (cnt-b1). [source:swissprot;acc:q15027]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2123\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5977.03\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6301.76\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05433\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
centaurin beta 2 (cnt-b2). [source:swissprot;acc:q15057]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2122\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
centaurin beta 5 (cnt-b5). [source:swissprot;acc:q96p50]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2121\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
centaurin gamma 1. [source:swissprot;acc:q99490]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2157\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5701.81\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6000.03\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0523\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
centaurin gamma 2. [source:swissprot;acc:q9upq3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2155\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
centaurin gamma 3. [source:swissprot;acc:q96p47]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2158\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
centromere protein j; centrosomal p4.1-associated protein; lyst-interacting protein lip1; lag-3-associated protein. [source:refseq;acc:nm\_018451]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2499\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8186.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7971.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02694\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/